“…These can be further combined with radiomics to identify populations that could be radiosensitive [186][187][188]. For example, Zhang et al combined gene expression, DNA methylation, and clinical data to identify eight radiosensitivityrelated genes (AR, WBP1, AKR1E2, FANCG, NR2C2AP, CXCR4, SYNE4, and WFDC2) [189], while Liu et al identified 12 genes (BEST2, TMPRSS15, FGF19, ALP1, KCNB2, CLDN6, IL17REL, RORB, DDX25, TDRD9, CELF3, and FABP7) that can aid in identifying population responses in head and neck cancer patients [190].…”